Alterity Therapeutics Ltd (ATHE) — Cash Flow Reinvestment Rate
Latest as of September 2023:
0.01x
Alterity Therapeutics Ltd (ATHE) has a Cash Flow Reinvestment Rate of 0.01x as of September 2023, reinvesting $8.00K (capex $4.00K plus investments $-4.00K) from operating cash flow of $549.00K. See Alterity Therapeutics Ltd (ATHE) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
0.01x
(Capex + Investments) / Operating CF
Total Reinvested
$8.00K
Capex + Investments
Operating Cash Flow
$549.00K
USD
Capital Expenditures
$4.00K
USD
Annual Cash Flow Reinvestment Rate for Alterity Therapeutics Ltd (None–None)
Year-by-year capital reinvestment analysis for Alterity Therapeutics Ltd. See Alterity Therapeutics Ltd (ATHE) financial flexibility to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow